PDF(394 KB)
Development Strategy of Integrative Pharmacy
Yong Zhang, Yixiu Zhao, Baofeng Yang
Strategic Study of CAE ›› 2021, Vol. 23 ›› Issue (1) : 185-192.
PDF(394 KB)
PDF(394 KB)
Development Strategy of Integrative Pharmacy
Integrative pharmacy is proposed owing to the increasingly profound understanding in complex diseases. It involves new drug research and development, innovation of traditional Chinese medicine, clinical practice of drugs, construction of the pharmacy discipline, cultivation of pharmaceutical professionals, and many other fields. To promote the practice of integrative pharmacy in China, this study clarifies the concept and connotation of integrative pharmacy and proposes future development strategies for integrative pharmacy. The research methods we used in this study includes literature research, academic exchange, and expert consultation. To integrate modern and traditional pharmacy, we suggest that clinical practice guidelines for integrative medication should be established and improved, innovative research of traditional Chinese medicine based on integrative thinking should be encouraged, and clinical application of Chinese and western medicine should be integrated and standardized. To promote the new drug research and development based on integrative pharmacy, the design idea of integrative drugs should be innovated, a drug evaluation system that adapts to integrative pharmacy should be developed,and a new drug development system should be established for integrative drugs. To promote the clinical application of integrative pharmacy, patient-centered clinical medication guidance should be further improved, individualized treatment should be encouraged, the clinical practice content of integrative pharmacy should be enriched, and the rational application of integrative drugs should be emphasized. To promote the construction of the integrative pharmacy discipline, the theoretical and practice curricula for undergraduate education should be enriched based on integrative pharmacy, and educational training and professional collaboration should be strengthened. Integrative pharmacy develops based on the theories and practices of modern pharmacy and integrates the theories and practices of all related disciplines of pharmacy. It is a new pharmacy theory and practice system that can promote human health and improve the existing medical system in China.
integrative pharmacy / integrative drugs / new drug development / drug evaluation / clinical medication guidance
| [1] |
樊代明. 整合医学的内涵与外延 [J]. 医学与哲学, 2017, 38(1): 7–13. Fan D M. The connotation and extension of holistic integrative medicine [J]. Medicine and Philosophy, 2017, 38(1): 7–13.
|
| [2] |
樊代明. 整合医学再探 [C]//樊代明. 整合医学——理论与实践. 西安: 世界图书出版公司, 2016: 55–66. Fan D M. Re-discussion for holistic integrated medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 55–66.
|
| [3] |
郭姣, 陈钢, 索蓄斌, 等. 整合药学——药学教育发展新时代 [J]. 药学教育, 2018, 34(3): 1–4. Guo J, Chen G, Suo X B, et al. Holistic integrated pharmacy: A new era of pharmaceutical education [J]. Pharmaceutical Education, 2018, 34(3): 1–4.
|
| [4] |
吴以岭. 络病诊治理论及药物开发中的整合医学思维 [C]//樊 代明. 整合医学——理论与实践③. 西安: 世界图书出版公司, 2018: 535–540. Wu Y L. Theory of diagnosis and treatment of collateral disease and holistic integrative medical thinking [C]//Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 535–540.
|
| [5] |
王广基. 整合药学大有可为 [C]//樊代明. 整合医学——理论与 实践③. 西安: 世界图书出版公司, 2018: 529–534. Wang G J. There is much to be done in integrative medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 529–534.
|
| [6] |
李锋. 整合中医药学的发展前途光明 [C]//樊代明. 整合医 学——理论与实践③. 西安: 世界图书出版公司, 2018: 515–517. Li F. The future of integrative traditional Chinese medicine is bright [C]//Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 515–517.
|
| [7] |
吴以岭, 常丽萍. “理论—临床—新药—实验—循证”中医药创 新发展新模式 [C]. 济南: 第十四届国际络病学大会, 2018. Wu Y L, Chang L P. “Theory-clinical-new drug-experimentevidence-based” new model of traditional Chinese medicine [C]. Ji’nan: The 14th International Congress of Collateral Disease, 2018.
|
| [8] |
Yao D N, Hu H, Harnett J E, et al. Integrating traditional Chinese medicines into professional community pharmacy practice in China: Key stakeholder perspectives [J]. European Journal of Integrative Medicine, 2020, 34: 1–8.
|
| [9] |
Tian X Y, Liu L. Drug discovery enters a new era with multi-target intervention strategy [J]. Chinese Journal of Integrative Medicine, 2012, 18(7): 539–542.
|
| [10] |
Gu S, Pei J F. Chinese herbal medicine meets biological networks of complex diseases: a computational perspective [J]. Evidencebased Complementary and Alternative Medicine, 2017, 2017: 1–7.
|
| [11] |
Wang Y, Fan X H, Qu H B, et al. Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine [J]. Current Topics in Medicinal Chemistry, 2012, 12(12): 1356–1362.
|
| [12] |
Chong C R, Sullivan D J. New uses for old drugs [J]. Nature, 2007, 448(7154): 645–646.
|
| [13] |
崔建梅, 尹大力. 药物重新定位策略在新药发现中的应用与进 展 [J]. 中国药学杂志, 2005, 40(20): 1524–1526. Cui J M, Yin D L. Application and progress of drug repositioning in discovering new drugs [J]. Chinese Pharmaceutical Journal, 2005, 40(20): 1524–1526.
|
| [14] |
Boguski M S, Mandl K D, Sukhatme V P. Drug discovery repurposing with a difference [J]. Science, 2009, 324(5933): 1394–1395.
|
| [15] |
樊代明. 医药互为师 [C]//樊代明. 整合医学——理论与实践. 西 安: 世界图书出版公司, 2016: 138–145. Fan D M. Medicine and drug are teachers to each other [C]//Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 138–145.
|
| [16] |
Li J, Zheng S, Chen B, et al. A survey of current trends in computational drug repositioning [J]. Briefings in Bioinformatics, 2016, 17(1): 2–12.
|
| [17] |
Seifirad S, Haghpanah V. Inappropriate modeling of chronic and complex disorders: How to reconsider the approach in the context of predictive, preventive and personalized medicine, and translational medicine [J]. The EPMA Journal, 2019, 3(10): 195– 209.
|
| [18] |
Cunha L, Horvath I, Ferreira S, et al. Preclinical imaging: An essential ally in modern biosciences [J]. Molecular Diagnosis & Therapy, 2014, 18(2): 153–173.
|
| [19] |
Gatley S J, Volkow N D, Wang G J, et al. PET imaging in clinical drug abuse research [J]. Current Pharmaceutical Design, 2005, 11(25): 3203–3219.
|
| [20] |
陈凯先. 新药创制: 趋势、挑战和策略思考 [J]. 中国食品药品监 管, 2015 (5): 24–25. Chen K X. Creation of new drugs: Trends, challenges, and strategic thinking [J]. China Food & Drug Administration Magazine, 2015 (5): 24–25.
|
| [21] |
樊代明. 合理用药和用药合理 [C]//樊代明. 整合医学——理论 与实践. 西安: 世界图书出版公司, 2016: 146–153. Fan D M. The rational use of drugs and reasonable medication [C]// Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 146–153.
|
| [22] |
杨宝峰. 整合药学之我见 [C]//樊代明. 整合医学——理论与实 践③. 西安: 世界图书出版公司, 2018: 518–522. Yang B F. My opinion on integrative medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 518–522.
|
| [23] |
左晖, 郭晓汐, 张宽仁. 分子靶向药物个体化肿瘤治疗与网络联 合进展 [J]. 中国新药与临床杂志, 2015, 34(5): 330–335. Zuo H, Guo X X, Zhang K R. Individualized application of molecular-targeted drugs against cancer and new development for network medicine therapy [J]. Chinese Journal of New Drugs and Clinical Remedies, 2015, 34(5): 330–335.
|
| [24] |
Vonelstein B, Papadopoulos N, Velculescu V E, et al. Cancer genome landscapes [J]. Science, 2013, 339(6127): 1546–1558.
|
| [25] |
曾浔, 蒋微琴, 尹巍巍, 等. 基于单细胞质谱流式技术的早期肝 癌区域免疫特性的研究 [C]. 上海: 第十三届全国免疫学学术大 会, 2018. Zeng X, Jiang W Q, Yin W W, et al. Study on regional immune characteristics of early hepatocellular carcinoma based on single cell mass spectrometry [C]. Shanghai: The 13th National Academic Congress of Immunology, 2018.
|
| [26] |
Maher B. Exome sequencing takes center stage in cancer profiling [J]. Nature, 2009, 459(7244): 146–147.
|
| [27] |
Angelo M, Bendall S C, Finck R, et al. Multiplexed ion beam imaging of human breast tumors [J]. Nature Medicine, 2014, 20(4): 436–442.
|
| [28] |
Harnett J E, Ung C, Hu H, et al. Advancing the pharmacist’s role in promoting the appropriate and safe use of dietary supplements [J]. Complementary Therapies in Medicine, 2019, 44: 174–181.
|
/
| 〈 |
|
〉 |
AI Summary
